Similar articles

• Timolol and bendrofluazide in the management of hypertension in general practice.

  Wheatley D. Wheatley D. Eur J Clin Pharmacol. 1978 Dec 18;14(5):319-24. doi: 10.1007/BF00611900. Eur J Clin Pharmacol. 1978. PMID: 365544 Clinical Trial.
• [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].

  Cherchi A, Sau F, Mercuro G, Seguro C, Lai O. Cherchi A, et al. Clin Ter. 1985 May 31;113(4):301-6. Clin Ter. 1985. PMID: 3893868 Clinical Trial. Italian. No abstract available.
• A crossover comparison of a timolol/bendrofluazide combination and methyldopa in essential hypertension.

  Spira M. Spira M. Curr Med Res Opin. 1977;5(3):252-7. doi: 10.1185/03007997709110174. Curr Med Res Opin. 1977. PMID: 162662 Clinical Trial. No abstract available.
• The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.

  Deering RB, Fox AS, Ison LJ. Deering RB, et al. J Int Med Res. 1977;5(2):114-9. doi: 10.1177/030006057700500207. J Int Med Res. 1977. PMID: 326593 Clinical Trial.
• Long term usage of Prestim (timolol/bendrofluazide) in the management of mild to moderate hypertension in general practice.

  Hosie J, Jones JC, Clifford PD. Hosie J, et al. Br J Clin Pract. 1983 Nov-Dec;37(11-12):393-6. Br J Clin Pract. 1983. PMID: 6367796 Clinical Trial. No abstract available.